PubMed:22061999 / 1322-1497 JSONTXT

{"project":"Glycan-Motif","denotations":[{"id":"T3","span":{"begin":146,"end":152},"obj":"https://glytoucan.org/Structures/Glycans/G82576YO"}],"text":"Additional purification was required to remove ∼15% of the plant-derived recombinant GCase that possessed potentially immunogenic (xylose- and/or fucose-containing) N-glycans."}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T3","span":{"begin":146,"end":152},"obj":"Glycan_Motif"}],"attributes":[{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G82576YO"}],"text":"Additional purification was required to remove ∼15% of the plant-derived recombinant GCase that possessed potentially immunogenic (xylose- and/or fucose-containing) N-glycans."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T3","span":{"begin":146,"end":152},"obj":"https://glytoucan.org/Structures/Glycans/G82576YO"}],"text":"Additional purification was required to remove ∼15% of the plant-derived recombinant GCase that possessed potentially immunogenic (xylose- and/or fucose-containing) N-glycans."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T18","span":{"begin":59,"end":64},"obj":"FMAID:214748"},{"id":"_T19","span":{"begin":131,"end":137},"obj":"FMAID:82804"},{"id":"_T20","span":{"begin":131,"end":137},"obj":"FMAID:196799"},{"id":"_T21","span":{"begin":146,"end":152},"obj":"FMAID:82790"},{"id":"_T22","span":{"begin":146,"end":152},"obj":"FMAID:196784"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Additional purification was required to remove ∼15% of the plant-derived recombinant GCase that possessed potentially immunogenic (xylose- and/or fucose-containing) N-glycans."}

{"project":"EDAM-topics","denotations":[{"id":"T17","span":{"begin":59,"end":64},"obj":"http://edamontology.org/topic_0780"},{"id":"T18","span":{"begin":118,"end":129},"obj":"http://edamontology.org/topic_2830"}],"text":"Additional purification was required to remove ∼15% of the plant-derived recombinant GCase that possessed potentially immunogenic (xylose- and/or fucose-containing) N-glycans."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T8","span":{"begin":0,"end":175},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":175},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":175},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Additional purification was required to remove ∼15% of the plant-derived recombinant GCase that possessed potentially immunogenic (xylose- and/or fucose-containing) N-glycans."}

{"project":"GlycoBiology-Motifs","denotations":[{"id":"T3","span":{"begin":165,"end":174},"obj":"http://rdf.glycoinfo.org/glycan/G00027MO"}],"text":"Additional purification was required to remove ∼15% of the plant-derived recombinant GCase that possessed potentially immunogenic (xylose- and/or fucose-containing) N-glycans."}